Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rangering i aksjer #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Aksjekurs
$4.66
Markedsverdi
$43.92M
Endring (1 dag)
-0.63%
Endring (1 år)
338.04%
Land
FR
Handel Theranexus Société Anonyme (ALTHX)

Kategori

P/S-forhold for Theranexus Société Anonyme (ALTHX)
P/S-forhold per July 2026 TTM: 38.28
Ifølge Theranexus Société Anonyme sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 38.28. Ved slutten av 2023 hadde selskapet et P/S-forhold på 29.32.
P/S-historikk for Theranexus Société Anonyme fra 2015 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 38.28 1,672.34%
2024 2.16 -92.63%
2023 29.32 30.81%
2022 22.42 -99.94%
2021 40.48K 15,636.51%
2020 257.27 1,228.70%
2019 19.36 -96.16%
2018 503.88 58.16%
2017 318.60 108.08%
2016 153.11 519.84%
2015 24.70 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
4.26 -88.86%
DK
10.29 -73.13%
US
4.31 -88.75%
US
6.44 -83.17%
BE
16.96 -55.70%
NL